MaxLinear Inc (MXL)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $4.73B
Last updated: Nov 17, 2026 at 4:43 PM ET
MaxLinear Inc (MXL) Stock Chart
MaxLinear (MXL) has a latest price of $51.42 on Nov 17, 2026, 59.9% below its 52-week high of $128.30. Its price rose 269.9% over the past 12 months. The month-end price rose 260.6% over the 10 years through Oct 2026, a compound annual rate of 13.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $128.03 in Jun 2026 and its lowest $9.99 in Apr 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MXL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MXL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.6%, and over 6 months it fell 45.8%. The month-end price rose 343.9% over the 3 years through Oct 2026, a compound annual rate of 64.3%.
| Period | Change |
|---|---|
| 1 month | -33.3% |
| 3 months | -22.6% |
| 6 months | -45.8% |
| 12 months | +269.9% |
| 12 months, with dividends | +269.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +343.9% | +64.3% |
| 5 years | +7.1% | +1.4% |
| 10 years | +260.6% | +13.7% |
Price by Year
Its best calendar year was 2021, when the price rose 97.4%, and its weakest was 2022, when it fell 55.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $67.47 | +287.1% |
| 2025 | $17.43 | -11.9% |
| 2024 | $19.78 | -16.8% |
| 2023 | $23.77 | -30.0% |
| 2022 | $33.95 | -55.0% |
| 2021 | $75.39 | +97.4% |
| 2020 | $38.19 | +80.0% |
| 2019 | $21.22 | +20.6% |
| 2018 | $17.60 | -33.4% |
| 2017 | $26.42 | +21.2% |
Trading Range
The price is 31.9% below its 50-day average of $75.46 and 17.3% below its 200-day average of $62.14.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $51.42 | |
| 52-week high | $128.30 | -59.9% |
| 52-week low | $12.87 | +299.5% |
| 50-day average | $75.46 | -31.9% |
| 200-day average | $62.14 | -17.3% |
Price Risk
Over 3 years, its largest fall from a peak was 65.4%.
| Measure | Value |
|---|---|
| 1-year beta | 3.91 |
| Largest fall, 1 year | -65.4% |
| Largest fall, 3 years | -65.4% |
Valuation
MaxLinear traded at 58.1x earnings at the end of 2025, against a 10-year median of 21.4x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MXL
What is MXL's 1-year price change?
MaxLinear's price rose 269.9% over the past 12 months. With dividends included, the 12-month total return was 269.9%.
What is MXL's 5-year price change?
MaxLinear's month-end price rose 7.1% over the 5 years through Oct 2026, a compound annual rate of 1.4%. These figures leave out dividends.
What is MXL's 52-week high and low?
MaxLinear's 52-week high is $128.30 and its 52-week low is $12.87. Its latest price of $51.42 on Nov 17, 2026 is 59.9% below the high.
What is MXL's beta?
MaxLinear's 1-year beta against the S&P 500 is 3.91, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 65.4%.
Is the MXL chart free?
Yes. Advanced Charting for MXL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MXL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors